CoChat

Brief Communication: Treatment of Enterococcus faecalis Endocarditis with Ampicillin plus Ceftriaxone

Gavaldà, Joan, Len, Oscar, Miró, José M., Muñoz, Patricia, Montejo, Miguel, Alarcón, Aristides, de la Torre-Cisneros, Julián, Peña, Carmen, Martínez-Lacasa, Xavier, Sarria, Cristina, Bou, Germán, Aguado, José M., Navas, Enrique, Romeu, Joan, Marco, Francesc, Torres, Carmen, Tornos, Pilar, Planes, Ana, Falcó, Vicenç, Almirante, Benito, Pahissa, Albert · 2007 · Annals of Internal Medicine

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Background High-level aminoglycoside resistance (HLAR) that precludes bactericidal synergism with penicillins or glycopeptides and nephrotoxicity related to aminoglycoside treatment are major problems in treating Enterococcus faecalis endocarditis. Objective To evaluate the efficacy and safety of ampicillin plus ceftriaxone for treating endocarditis due to E. faecalis with and without HLAR. Design Observational, open-label, nonrandomized, multicenter clinical trial. Setting 13 centers in Spain. Patients 21 patients with HLAR E. faecalis endocarditis and 22 patients with non-HLAR E. faecalis endocarditis. All were at risk for nephrotoxicity related to aminoglycoside use. Intervention 6-week course of intravenous ampicillin, 2 g every 4 hours, plus intravenous ceftriaxone, 2 g every 12 hours. Measurements Clinical and microbiological outcomes. Results The clinical cure rate at 3 months was 67.4% (29 of 43 patients) among all episodes. During treatment, 28.6% of patients with HLAR E. faecalis endocarditis and 18.2% of patients with non-HLAR E. faecalis endocarditis died of infection-related causes. The rate of clinical and microbiological cure in patients who completed the protocol was 100% in the HLAR E. faecalis endocarditis group. No episodes of breakthrough bacteremia occurred, although there were 2 relapses in the non-HLAR E. faecalis endocarditis group. Treatment was withdrawn in 1 case because of fever and skin rash. Limitations The study had a small sample and was observ…

Overview

Integrity signals

Registry

Crossref · 10.7326/0003-4819-146-8-200704170-00008

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 20 references

Research works printed but not linked: 3

  1. Moellering RC, 1970, Antimicrobial Agents Chemother (Bethesda), 10, 335
  2. Cirak MY, 1998, Acta Microbiol Pol, 47, 267
  3. Olesen HV, 2002, Ugeskr Laeger, 164, 2386

Cited by

See all 220

Metadata

Authors
Gavaldà, J., Len, O., Miró, J. M., Muñoz, P., Montejo, M., Alarcón, A., de la Torre-Cisneros, J., Peña, C., Martínez-Lacasa, X., Sarria, C., Bou, G., Aguado, J. M., Navas, E., Romeu, J., Marco, F., Torres, C., Tornos, P., Planes, A., Falcó, V., Almirante, B., & Pahissa, A.
Affiliations
  • Universidad de La Rioja (ES)
  • From the Hospital Universitari Vall d'Hebron, Institut d'Investigacions Biomediques August Pi i Sunyer, Hospital de Bellvitge, Mutua de Terrassa, and Hospital Germans Tries i Pujol, Barcelona, Spain; Hospital Gregorio Marañón, Hospital Universitario de La Princesa, Hospital Doce de Octubre, and Hospital Ramón y Cajal, Madrid, Spain; Hospital de Cruces, Barakaldo, Spain; Hospital Virgen del Rocío, Seville, Spain; Hospital Reina Sofía, Córdoba, Spain;
Corresponding author
Gavaldà, Joan
Venue
Annals of Internal Medicine
Published
2007-04-17
Volume
146
Issue
8
Pages
574-579
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2161863262
Cited by
202
References
20
Citations by year
2026: 3 · 2025: 7 · 2024: 4 · 2023: 12 · 2022: 9 · 2021: 9 · 2020: 14 · 2019: 6 · 2018: 10 · 2017: 7 · 2016: 7 · 2015: 16 · 2014: 10 · 2013: 18 · 2012: 11
FWCI
10.55
Type
journal article
Language
en
Open access
closed
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
  • Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
  • Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
Keywords
Enterococcus faecalis, infective endocarditis, high-level aminoglycoside resistance, ampicillin, ceftriaxone, combination antibiotic therapy, nephrotoxicity, clinical cure rate, microbiological cure, relapse, treatment safety
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Aminoglycosides, Ampicillin, Anti-Bacterial Agents, Ceftriaxone, Child, Child, Preschool, Drug Resistance, Microbial, Drug Therapy, Combination, Endocarditis, Bacterial, Female, Humans, Infant, Male, Middle Aged, Enterococcus faecalis, Treatment Failure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Brief Communication: Treatment of Enterococcus faecalis Endocarditis with Ampicillin plus Ceftriaxone. https://app.cochat.ai/papers/10.7326/0003-4819-146-8-200704170-00008
The paper
Gavaldà, J., Len, O., Miró, J. M., Muñoz, P., Montejo, M., Alarcón, A., de la Torre-Cisneros, J., Peña, C., Martínez-Lacasa, X., Sarria, C., Bou, G., Aguado, J. M., Navas, E., Romeu, J., Marco, F., Torres, C., Tornos, P., Planes, A., Falcó, V., . . . Pahissa, A. (2007). Brief Communication: Treatment of Enterococcus faecalis Endocarditis with Ampicillin plus Ceftriaxone. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-146-8-200704170-00008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.